Abstract
Nanoscale engineering is revolutionizing disease detection and prevention. Viruses have made a remarkable contribution to these developments because they can function as prefabricated nanoparticles that have naturally evolved to deliver cargos to cells and tissues. The Steinmetz Lab has established a library of plant virus-based nanoparticles and carried out comprehensive structure–function studies that have shown how to tailor these nanomaterials appropriately for biomedical applications. By exploiting the benefits of synthetic and chemical biology, plant virus-based nanotechnologies are being developed for applications in molecular imaging and drug delivery, and as cancer vaccines and immunotherapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adis International Ltd. (2003). HIV Gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV Gp120 Vaccine - Genentech, HIV Gp120 Vaccine AIDSVAX - VaxGen, HIV Vaccine AIDSVAX – VaxGen. Drugs in R&D, 4(4), 249–253.
Aljabali, A. A. A., Lomonossoff, G. P., & Evans, D. J. (2011). CPMV-polyelectrolyte-templated gold nanoparticles. Biomacromolecules, 12(7), 2723–2728.
Bruckman, M. A., Kaur, G., Lee, L. A., Xie, F., Sepulveda, J., Breitenkamp, R., Zhang, X., Joralemon, M., Russell, T. P., Emrick, T., & Wang, Q. (2008). Surface modification of tobacco mosaic virus with “click” chemistry. Chembiochem: A European Journal of Chemical Biology, 9(4), 519–523.
Bruckman, M. A., Jiang, K., Simpson, E. J., Randolph, L. N., Luyt, L. G., Yu, X., & Steinmetz, N. F. (2014a). Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus. Nano Letters, 14(3), 1551–1558.
Bruckman, M. A., Randolph, L. N., VanMeter, A., Hern, S., Shoffstall, A. J., Taurog, R. E., & Steinmetz, N. F. (2014b). Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology, 449, 163–173.
Bruckman, M. A., VanMeter, A., & Steinmetz, N. F. (2015). Nanomanufacturing of tobacco mosaic virus-based spherical biomaterials using a continuous flow method. ACS Biomaterials Science & Engineering, 1(1), 13–18.
Cao, J., Guenther, R. H., Sit, T. L., Lommel, S. A., Opperman, C. H., & Willoughby, J. A. (2015). Development of abamectin loaded plant virus nanoparticles for efficacious plant parasitic nematode control. ACS Applied Materials & Interfaces, 7(18), 9546–9553.
Chackerian, B., Rangel, M., Hunter, Z., & Peabody, D. S. (2006). Virus and virus-like particle-based immunogens for Alzheimer’s disease induce antibody responses against amyloid-beta without concomitant T cell responses. Vaccine, 24(37–39), 6321–6331.
Chariou, P. L., & Steinmetz, N. F. (2017). Delivery of pesticides to plant parasitic nematodes using tobacco mild green mosaic virus as a nanocarrier. ACS Nano, 11(5), 4719–4730.
Czapar, A. E., Zheng, Y.-R., Riddell, I. A., Shukla, S., Awuah, S. G., Lippard, S. J., & Steinmetz, N. F. (2016). Tobacco mosaic virus delivery of phenanthriplatin for cancer therapy. ACS Nano, 10(4), 4119–4126.
Douglas, T., Strable, E., Willits, D., Aitouchen, A., Libera, M., & Young, M. (2002). Protein engineering of a viral cage for constrained nanomaterials synthesis. Advanced Materials, 14(6), 415–418.
Eber, F. J., Eiben, S., Jeske, H., & Wege, C. (2014). RNA-controlled assembly of tobacco mosaic virus-derived complex structures: From nanoboomerangs to tetrapods. Nanoscale, 7(1), 344–355.
Farkas, M. E., Aanei, I. L., Behrens, C. R., Tong, G. J., Murphy, S. T., O’Neil, J. P., & Francis, M. B. (2013). PET imaging and biodistribution of chemically modified bacteriophage MS2. Molecular Pharmaceutics, 10(1), 69–76.
Fulurija, A., Lutz, T. A., Sladko, K., Osto, M., Wielinga, P. Y., Bachmann, M. F., & Saudan, P. (2008). Vaccination against GIP for the treatment of obesity. PloS One, 3(9), e3163.
Geiger, F. C., Eber, F. J., Eiben, S., Mueller, A., Jeske, H., Spatz, J. P., & Wege, C. (2013). TMV nanorods with programmed longitudinal domains of differently addressable coat proteins. Nanoscale, 5(9), 3808–3816.
Gerlich, W. H. (2015). Prophylactic vaccination against hepatitis B: Achievements, challenges and perspectives. Medical Microbiology and Immunology, 204(1), 39–55.
Harper, D. M. (2009). Currently approved prophylactic HPV vaccines. Expert Review of Vaccines, 8(12), 1663–1679.
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science (New York, N.Y.), 303(5663), 1526–1529.
Henao-Restrepo, A. M., Camacho, A., Longini, I. M., Watson, C. H., Edmunds, W. J., Egger, M., Carroll, M. W., Dean, N. E., Diatta, I., Doumbia, M., Draguez, B., Duraffour, S., Enwere, G., Grais, R., Gunther, S., Gsell, P.-S., Hossmann, S., Watle, S. V., Kondé, M. K., Kéïta, S., Kone, S., Kuisma, E., Levine, M. M., Mandal, S., Mauget, T., Norheim, G., Riveros, X., Soumah, A., Trelle, S., Vicari, A. S., Røttingen, J.-A., & Kieny, M.-P. (2017). Efficacy and effectiveness of an RVSV-vectored vaccine in preventing Ebola virus disease: Final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). The Lancet, 389(10068), 505–518.
Hortobagyi, G. N. (2005). Trastuzumab in the treatment of breast cancer. New England Journal of Medicine, 353(16), 1734–1736.
Hou, B., Saudan, P., Ott, G., Wheeler, M. L., Ji, M., Kuzmich, L., Lee, L. M., Coffman, R. L., Bachmann, M. F., & DeFranco, A. L. (2011). Selective utilization of toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity, 34(3), 375–384.
Hovlid, M. L., Lau, J. L., Breitenkamp, K., Higginson, C. J., Laufer, B., Manchester, M., & Finn, M. G. (2014). Encapsidated atom-transfer radical polymerization in Qβ virus-like nanoparticles. ACS Nano, 8(8), 8003–8014.
Huang, X., Bronstein, L. M., Retrum, J., Dufort, C., Tsvetkova, I., Aniagyei, S., Stein, B., Stucky, G., McKenna, B., Remmes, N., Baxter, D., Kao, C. C., & Dragnea, B. (2007). Self-assembled virus-like particles with magnetic cores. Nano Letters, 7(8), 2407–2416.
Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H. J., Kopf, M., & Bachmann, M. F. (2007). TLR9 signaling in B cells determines class switch recombination to IgG2a. Journal of Immunology (Baltimore, MD: 1950), 178(4), 2415–2420.
Jhaveri, K., & Esteva, F. J. (2014). Pertuzumab in the treatment of HER2+ breast cancer. Journal of the National Comprehensive Cancer Network: JNCCN, 12(4), 591–598.
Klem, M. T., Willits, D., Young, M., & Douglas, T. (2003). 2-D array formation of genetically engineered viral cages on Au surfaces and imaging by atomic force microscopy. Journal of the American Chemical Society, 125(36), 10806–10807.
Knez, M., Bittner, A. M., Boes, F., Wege, C., Jeske, H., Maiβ, E., & Kern, K. (2003). Biotemplate synthesis of 3-Nm nickel and cobalt nanowires. Nano Letters, 3(8), 1079–1082.
Knobler, S., Lederberg, J., Pray, L. A., & Institute of Medicine (U.S.) (Eds.). (2002). Considerations for viral disease eradication: Lessons learned and future strategies: Workshop summary. Washington, DC: National Academy Press.
Kohlhapp, F. J., Zloza, A., & Kaufman, H. L. (2015). Talimogene laherparepvec (T-VEC) as cancer immunotherapy. Drugs of Today (Barcelona, Spain: 1998), 51(9), 549–558.
Koonin, E. V., Senkevich, T. G., & Dolja, V. V. (2006). The ancient virus world and evolution of cells. Biology Direct, 1, 29.
Le, D. H. T., Lee, K. L., Shukla, S., Commandeur, U., & Steinmetz, N. F. (2017). Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy. Nanoscale, 9(6), 2348–2357.
Lebel, M.-È., Chartrand, K., Tarrab, E., Savard, P., Leclerc, D., & Lamarre, A. (2016). Potentiating cancer immunotherapy using papaya mosaic virus-derived nanoparticles. Nano Letters, 16(3), 1826–1832.
Lee, K. L., Carpenter, B. L., Wen, A. M., Ghiladi, R. A., & Steinmetz, N. F. (2016). High aspect ratio nanotubes formed by tobacco mosaic virus for delivery of photodynamic agents targeting melanoma. ACS Biomaterials Science & Engineering, 2(5), 838–844.
Lee, K. L., Murray, A. A., Le, D. H. T., Sheen, M. R., Shukla, S., Commandeur, U., Fiering, S., & Steinmetz, N. F. (2017). Combination of plant virus nanoparticle-based in situ vaccination with chemotherapy potentiates antitumor response. Nano Letters, 17(7), 4019–4028.
Lizotte, P. H., Wen, A. M., Sheen, M. R., Fields, J., Rojanasopondist, P., Steinmetz, N. F., & Fiering, S. (2015). In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. Nature Nanotechnology, 11(3), 295–303.
Loo, L., Guenther, R. H., Lommel, S. A., & Franzen, S. (2007). Encapsidation of nanoparticles by red clover necrotic mosaic virus. Journal of the American Chemical Society, 129(36), 11111–11117.
López-Macías, C., Ferat-Osorio, E., Tenorio-Calvo, A., Isibasi, A., Talavera, J., Arteaga-Ruiz, O., Arriaga-Pizano, L., Hickman, S. P., Allende, M., Lenhard, K., Pincus, S., Connolly, K., Raghunandan, R., Smith, G., & Glenn, G. (2011). Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico. Vaccine, 29(44), 7826–7834.
Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014). Bioengineering virus-like particles as vaccines: Virus-like particles as vaccines. Biotechnology and Bioengineering, 111(3), 425–440.
Luque, D., de la Escosura, A., Snijder, J., Brasch, M., Burnley, R. J., Koay, M. S. T., Carrascosa, J. L., Wuite, G. J. L., Roos, W. H., Heck, A. J. R., Cornelissen, J. J. L. M., Torres, T., & Castón, J. R. (2013). Self-assembly and characterization of small and monodisperse dye nanospheres in a protein cage. Chemical Science, 5(2), 575–581.
Miller, R. A., Presley, A. D., & Francis, M. B. (2007). Self-assembling light-harvesting systems from synthetically modified tobacco mosaic virus coat proteins. Journal of the American Chemical Society, 129(11), 3104–3109.
Pokorski, J. K., & Steinmetz, N. F. (2011). The art of engineering viral nanoparticles. Molecular Pharmaceutics, 8(1), 29–43.
Prangishvili, D., & Garrett, R. A. (2005). Viruses of hyperthermophilic crenarchaea. Trends in Microbiology, 13(11), 535–542.
Prangishvili, D., Forterre, P., & Garrett, R. A. (2006). Viruses of the Archaea: A unifying view. Nature Reviews Microbiology, 4(11), 837–848.
Quentin, M., Abad, P., & Favery, B. (2013). Plant parasitic nematode effectors target host defense and nuclear functions to establish feeding cells. Frontiers in Plant Science, 4, 53.
Rachel, R., Bettstetter, M., Hedlund, B. P., Häring, M., Kessler, A., Stetter, K. O., & Prangishvili, D. (2002). Remarkable morphological diversity of viruses and virus-like particles in hot terrestrial environments. Archives of Virology, 147(12), 2419–2429.
Riedel, S. (2005). Edward Jenner and the history of smallpox and vaccination. Proceedings (Baylor University Medical Center), 18(1), 21–25.
Shukla, S., Ablack, A. L., Wen, A. M., Lee, K. L., Lewis, J. D., & Steinmetz, N. F. (2013). Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle potato virus X. Molecular Pharmaceutics, 10(1), 33–42.
Shukla, S., Eber, F. J., Nagarajan, A. S., DiFranco, N. A., Schmidt, N., Wen, A. M., Eiben, S., Twyman, R. M., Wege, C., & Steinmetz, N. F. (2015). The impact of aspect ratio on the biodistribution and tumor homing of rigid soft-matter nanorods. Advanced Healthcare Materials, 4(6), 874–882.
Shukla, S., Dorand, R. D., Myers, J. T., Woods, S. E., Gulati, N. M., Stewart, P. L., Commandeur, U., Huang, A. Y., & Steinmetz, N. F. (2016). Multiple administrations of viral nanoparticles alter in vivo behavior—Insights from intravital microscopy. ACS Biomaterials Science & Engineering, 2(5), 829–837.
Shukla, S., Myers, J. T., Woods, S. E., Gong, X., Czapar, A. E., Commandeur, U., Huang, A. Y., Levine, A. D., & Steinmetz, N. F. (2017). Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers. Biomaterials, 121, 15–27.
Sonderegger, I., Röhn, T. A., Kurrer, M. O., Iezzi, G., Zou, Y., Kastelein, R. A., Bachmann, M. F., & Kopf, M. (2006). Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. European Journal of Immunology, 36(11), 2849–2856.
Spohn, G., Keller, I., Beck, M., Grest, P., Jennings, G. T., & Bachmann, M. F. (2008). Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. European Journal of Immunology, 38(3), 877–887.
Tissot, A. C., Maurer, P., Nussberger, J., Sabat, R., Pfister, T., Ignatenko, S., Volk, H.-D., Stocker, H., Müller, P., Jennings, G. T., Wagner, F., & Bachmann, M. F. (2008). Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: A double-blind, randomised, placebo-controlled phase IIa study. The Lancet, 371(9615), 821–827.
Wang, Q., Lin, T., Johnson, J. E., & Finn, M. G. (2002). Natural supramolecular building blocks. Chemistry & Biology, 9(7), 813–819.
Wen, A. M., & Steinmetz, N. F. (2014). The aspect ratio of nanoparticle assemblies and the spatial arrangement of ligands can be optimized to enhance the targeting of cancer cells. Advanced Healthcare Materials, 3(11), 1739–1744.
Wen, A. M., & Steinmetz, N. F. (2016). Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chemical Society Reviews, 45(15), 4074–4126.
Wen, A. M., Shukla, S., Saxena, P., Aljabali, A. A. A., Yildiz, I., Dey, S., Mealy, J. E., Yang, A. C., Evans, D. J., Lomonossoff, G. P., & Steinmetz, N. F. (2012). Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromolecules, 13(12), 3990–4001.
Wen, A. M., Rambhia, P. H., French, R. H., & Steinmetz, N. F. (2013). Design rules for nanomedical engineering: From physical virology to the applications of virus-based materials in medicine. Journal of Biological Physics, 39(2), 301–325.
Wen, A. M., Le, N., Zhou, X., Steinmetz, N. F., & Popkin, D. L. (2015a). Tropism of CPMV to professional antigen presenting cells enables a platform to eliminate chronic infections. ACS Biomaterials Science & Engineering, 1(11), 1050–1054.
Wen, A. M., Wang, Y., Jiang, K., Hsu, G. C., Gao, H., Lee, K. L., Yang, A. C., Yu, X., Simon, D. I., & Steinmetz, N. F. (2015b). Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging. Journal of Materials Chemistry. B, Materials for Biology and Medicine, 3(29), 6037–6045.
Wen, A. M., Lee, K. L., Cao, P., Pangilinan, K., Carpenter, B. L., Lam, P., Veliz, F. A., Ghiladi, R. A., Advincula, R. C., & Steinmetz, N. F. (2016). Utilizing viral nanoparticle/dendron hybrid conjugates in photodynamic therapy for dual delivery to macrophages and cancer cells. Bioconjugate Chemistry, 27(5), 1227–1235.
Yildiz, I., Lee, K. L., Chen, K., Shukla, S., & Steinmetz, N. F. (2013). Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: Cargo-loading and delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society, 172(2), 568–578.
Acknowledgements
This was funded in part by the following grants to N.F.S.: NIH R01-CA224605, NIH R01-HL137674, NIH U01-CA218292, NIH R21-EB024874, NIH R01-CA202814, NIH R21-HL121130, NIH R21-EB020946, American Cancer Society 128319-RSG-15-144-01-CDD, NSF DMR-1452257 CAREER, NSF CMMI-1333651, NSF CHE-1306447, and Susan G. Komen CCR14298962. A.M.W. was supported through the following fellowships: NIH T32 EB007509, AHA 15PRE25710044, and NIH F31 HL129703, and K.L.L. was supported by the following fellowships: NIH T32 EB007509 and NIH R25 CA148052.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wen, A.M., Lee, K.L., Steinmetz, N.F. (2020). Plant Virus-Based Nanotechnologies. In: Norris, P., Friedersdorf, L. (eds) Women in Nanotechnology. Women in Engineering and Science. Springer, Cham. https://doi.org/10.1007/978-3-030-19951-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-19951-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19950-0
Online ISBN: 978-3-030-19951-7
eBook Packages: EngineeringEngineering (R0)